In this context, the endogenous tissue inhibitor of metalloproteinase-1 (TIMP-1) was shown to suppress tumor neovascularization and the angiogenic capacity of endothelial cells [5,6,7,8,9]. This evidence concerns the gene TIMP1 and neoplasm.